UNITED STATES – As reported in an online news article published by www.abc10.com, many questions remain as to how serious the cancer risk is for patients who have continued taking their blood pressure medication subject to recall. One year after the United States Food and Drug Administration (FDA) issued its first recall … [Read more...]
Update on Blood Pressure Medication Recalls
Valisure Confirms Fourth Carcinogen Found in Valsartan
Online Pharmacy Informs the FDA of the Presence of a Known Carcinogen in Certain Blood Pressure Medications NEW HAVEN, CONNECTICUT – As reported online by www.cardiovascularbusiness.com, online pharmacy Valisure recently discovered a fourth carcinogen, N,N-Dimethylformamide (DMF), has been found in certain blood pressure … [Read more...]
Another Dangerous Solvent Found in Valsartan
Pharmacist.com, an online resource for pharmacists, healthcare professionals and the general public, reported that drug companies recently announced that cancer-causing solvent was detected in Valsartan high blood pressure medication. The online pharmacy company known as Valisure said that dimethylformamide, or DMF for short, is … [Read more...]
Another Carcinogen Found in Valsartan
NEW HAVEN, Conn. — Valisure, a New Haven, Connecticut online pharmacy who distributes the high blood pressure medication valsartan, alerted the U.S. Food and Drug Administration to the presence of a known carcinogenic substance in its medication according to an article appearing in the Bloomberg.com. Valisure tested six samples of … [Read more...]
Aurobindo Pharma Recalls Its Valsartan Drug
UNITED STATES – The drug manufacturer Aurobindo Pharma USA Inc. is recalling a blood pressure medication over potential cancer risks posed by the drug. The medication contains a substance that could be cancerous to patients. Aurobindo Pharma detected a substance called N-nitrosodiethylamine (NDEA) in numerous lots of its blood … [Read more...]
Leave a Reply
You must be logged in to post a comment.